Novel, arylsusfonamide compounds for the treatment of...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 295/04 (2006.01) A61K 31/4164 (2006.01) A61K 31/439 (2006.01) A61K 31/445 (2006.01) A61K 31/495 (2006.01) A61K 31/496 (2006.01) A61K 31/551 (2006.01) A61P 3/04 (2006.01) C07D 211/46 (2006.01) C07D 215/36 (2006.01) C07D 233/56 (2006.01) C07D 241/04 (2006.01) C07D 243/08 (2006.01) C07D 261/10 (2006.01) C07D 295/135 (2006.01) C07D 401/12 (2006.01) C07D 409/14 (2006.01) C07D 413/12 (2006.01) C07D 453/02 (2006.01) C07D 487/04 (2006.01) C07D 487/08 (2006.01)

Patent

CA 2443724

The present invention relates to substituted bis-arylsulfonamide and arylsulfonamide compounds of the general formula (I) or the formula (II), which compounds are potentially useful for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes and/or disorders of the central nervous system.

L'invention concerne des composés bis-arylsulfonamide et arylsulfonamide substitués de formule générale (I) ou de formule (II), ces composés étant potentiellement utiles pour la prophylaxie et le traitement d'états médicaux associés à l'obésité, aux diabètes de type II et/ou à des troubles du système nerveux central.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel, arylsusfonamide compounds for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel, arylsusfonamide compounds for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel, arylsusfonamide compounds for the treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2004270

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.